Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Igm Biosciences Inc (NQ: IGMS )

20.92 -0.08 (-0.38%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 2, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 295,814
Open 20.29
Bid (Size) 15.98 (3)
Ask (Size) 23.11 (1)
Prev. Close 21.00
Today's Range 19.66 - 21.53
52wk Range 12.67 - 53.92
Shares Outstanding 25,905,471
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
IGM Biosciences to Present at the Bank of America Biotech SMID Cap Conference
From IGM Biosciences, Inc.
Via Globe NewsWire
IGM Biosciences's Return On Capital Employed Overview
 
Via Benzinga

Performance

YTD
-29.63%
-29.63%
1 Month
+24.75%
+24.75%
3 Month
+12.35%
+12.35%
6 Month
+27.02%
+27.02%
1 Year
-56.36%
-56.36%

More News

Read More
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Via Benzinga
IGM Biosciences: Q2 Earnings Insights
Via Benzinga
Unity Software, Amazon, Doximity And Other Big Gainers From Friday
Via Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Via Benzinga
$10 Million Bet On Rain Therapeutics? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
IGM Biosciences to Present at Three Upcoming Investor Conferences
From IGM Biosciences, Inc.
Via Globe NewsWire
IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update
From IGM Biosciences, Inc.
Via Globe NewsWire
IGM Biosciences and ADC Therapeutics Announce Clinical Collaboration Agreement to Evaluate Imvotamab (IGM-2323) in Combination with ZYNLONTA® in Patients with Relapsed or Refractory B Cell Non-Hodgkin’s Lymphoma
From IGM Biosciences, Inc.
Via Globe NewsWire
Analyst Ratings for IGM Biosciences
Via Benzinga
Why Did Truist Lower IGM Biosciences' Price Target?
Via Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Via Benzinga
Why Is IGM Biosciences (IGMS) Stock Up Today?
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
Via Benzinga
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Via Benzinga
Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
10 Biggest Price Target Changes For Wednesday
Via Benzinga
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
Via Benzinga
53 Biggest Movers From Yesterday
Via Benzinga
8 Stocks Halted In Tuesday's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.